Growth HormoneModerate Evidence

CJC-1295

Also known as: Modified GRF(1-29), DAC:GRF

Long-acting GHRH analog that stimulates sustained growth hormone release.

Evidence

Moderate

FDA status

Not FDA-approved

Source

Synthetic GHRH analog

Overview

Long-acting GHRH analog that stimulates sustained growth hormone release.

Mechanism of Action

Binds GHRH receptors on pituitary somatotrophs, activates adenylyl cyclase/cAMP/PKA cascade, enhances GH gene transcription and protein synthesis, resists degradation for prolonged action (5.8-8.1 day half-life), raises GH and IGF-1 levels in small human studies.

What research has looked at

Effects reported in studies, not proven benefits. See the evidence section below for how strong the research is.

  • Increases growth hormone and IGF-1 levels
  • Enhances muscle growth and recovery
  • Improves body composition
  • Supports fat loss
  • Better sleep quality
  • Enhanced tissue repair
  • Improved skin quality

Researched for

Research topics, not approved uses.

Growth hormone deficiencyAge-related GH declinePoor recovery and healingBody compositionAge-related changes

How Gabriel approaches peptides

Through Gabriel, licensed clinicians may prescribe BPC-157, TB-500, MOTS-c, epitalon and semax (nasal) as compounded medications from licensed 503A pharmacies, under HHS's October 28, 2026 interim policy, and only when appropriate. They are not FDA-approved, and Gabriel never gives peptide dosing. CJC-1295 isn't prescribed through Gabriel. If you're thinking about it, Gabriel can help you find a licensed clinician to look at the cause of what you're dealing with and the options with stronger evidence.

Read the peptide therapy guide

Research & Evidence

Evidence Level
Moderate
Studies

Clinical trials in healthy adults, ongoing research

Summary

Small human studies showed raised GH and IGF-1 levels. Development stopped, and there are no long-term safety data. FDA has raised safety concerns about it.

Safety Information

Potential Side Effects

  • •Injection site reactions
  • •Water retention
  • •Increased hunger
  • •Numbness/tingling
  • •Fatigue

Contraindications

  • Active cancer
  • Diabetic retinopathy
  • Pregnancy
  • Breastfeeding

Interactions

  • ⚠May affect glucose metabolism
  • ⚠Caution with insulin

Quick Facts

CategoryGrowth Hormone
SourceSynthetic GHRH analog
StatusNot FDA-approved; FDA has raised safety concerns